Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety Study of Viaskin Peanut to Treat Peanut Allergy

ClinicalTrials.gov ID: NCT02916446

Public ClinicalTrials.gov record NCT02916446. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02916446
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
DBV Technologies
Industry
Enrollment
393 participants

Conditions and interventions

Conditions

Interventions

  • Viaskin Peanut 250 mcg Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
4 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2016
Primary completion
Sep 21, 2017
Completion
Oct 6, 2020
Last update posted
Feb 2, 2021

2016 – 2020

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
24
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
Allergy & Asthma Associates of Southern California Mission Viejo California 92691
Palos Verdes Medical Group Rolling Hills Estates California 90274
Stanford University School of Medicine Stanford California 94304
Children's Hospital Colorado Aurora Colorado 80045
National Jewish Health Denver Colorado 80206
Sarasota Clinical Research Sarasota Florida 34239
Atlanta Allergy & Asthma Clinic Marietta Georgia 30060
Ann & Robert H. Lurie Children's Hospital of CHicago Chicago Illinois 60611
Sneeze, Wheeze and Itch Associates,Clinical Research Normal Illinois 62704
Johns Hopkins Hospital Baltimore Maryland 21205
Massachusetts General Hospital Boston Massachusetts 02114
Boston Childrens' Hospital Boston Massachusetts 02115
Clinical Research Institute Plymouth Minnesota 55441
Children's Mercy Hospital Kansas City Missouri 64108
The Asthma and Allergy Center Bellevue Nebraska 68123
Mount Sinai Medical Center New York New York 10029
The University of North Carolina - Chapell Hill Chapel Hill North Carolina 27599
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
National Allergy and Asthma Research Charleston South Carolina 29407
Children's Medical Center of Dallas Dallas Texas 75390-9105
Baylor College of Medicine - Texas Children's Hospital Houston Texas 77030
Sylvana Research San Antonio Texas 78229
STAAMP Research San Antonio Texas 78251
ASTHMA, Inc. Clinical Research Seattle Washington 98115-2060

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02916446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02916446 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →